Fusion Antibodies completes 'difficult' restructuring proces

Fusion Antibodies completes 'difficult' restructuring process as directors are paid in shares

BELFAST-based antibody developer Fusion Antibodies has completed what is says has been a "difficult" restructuring process, which has involved a new share placing to raise funds.

Related Keywords

Belfast , United Kingdom , Adrian Kinkaid , Queen University , Fusion Antibodies , Stock Market , R Adrian Kinkaid , Share Placing , Restructuring , ,

© 2025 Vimarsana